FDA clears Coreline's AI-based radiotherapy autocontouring system

2020 02 24 17 44 7728 Clearance Stamp 400

The U.S. Food and Drug Administration (FDA) has cleared advanced visualization and AI software developer Coreline Soft's AI-based radiotherapy autocontouring system, AView RT ACS.

The system provides deep learning-based autosegmentation of organs on CT and generates head and neck, breast, abdomen, and pelvis contouring in an RT-DICOM format, the company said.

Page 1 of 422
Next Page